melatonin has been researched along with alprostadil in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Backon, J | 1 |
| Cardinali, DP; Pereyra, E; Rita, MN; Solveyra, CG | 1 |
| Nash, MS; Osborne, NN | 1 |
| Akdemir, I; Gursu, F; Kaplan, M; Kilic, N; Ozveren, F; Tiftikci, M; Topsakal, C | 1 |
| Akkus, MA; Aygen, E; Bülbüller, N; Cetinkaya, Z; Cifter, C; Dogru, O; Ilhan, YS | 1 |
| Sood, MR | 1 |
| Canpolat, FE; Cekmez, F; Cetinkaya, M; Kafa, IM; Sarıcı, SÜ; Tayman, C; Tunc, T; Uysal, S | 1 |
| Dolińska, B; Ostróżka-Cieślik, A | 1 |
1 review(s) available for melatonin and alprostadil
| Article | Year |
|---|---|
The Role of Hormones and Trophic Factors as Components of Preservation Solutions in Protection of Renal Function before Transplantation: A Review of the Literature.
Topics: Adrenocorticotropic Hormone; Alprostadil; Animals; Hormones; Humans; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Transplantation; Melatonin; Organ Preservation; Organ Preservation Solutions; Prolactin; Reperfusion Injury; Thyrotropin | 2020 |
9 other study(ies) available for melatonin and alprostadil
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
How information processing mode could affect prostaglandin E1 metabolism and lung inactivation: relevance of hemispheric specialization, neurotransmitter asymmetry and brain reactivity.
Topics: Alprostadil; beta-Endorphin; Brain; Cognition; Depression; Endorphins; Humans; Lung; Melatonin; Models, Psychological; Neurotransmitter Agents; Prostaglandins E; Schizophrenia | 1984 |
Role of prostaglandins in rat pineal neuroeffector junction. Changes in melatonin and norepinephrine release in vitro.
Topics: Alprostadil; Animals; Aspirin; Dinoprost; Dinoprostone; Indomethacin; Male; Mefenamic Acid; Melatonin; Norepinephrine; Pineal Gland; Potassium; Prostaglandins; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains | 1982 |
Agonist-induced effects on cyclic AMP metabolism are affected in pigment epithelial cells of the Royal College of Surgeons rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprostadil; Animals; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprostone; Fibroblast Growth Factor 2; Imidazoles; Isoproterenol; Kinetics; Melatonin; Pigment Epithelium of Eye; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta-2; Receptors, Purinergic P1; Serotonin | 1995 |
Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury.
Topics: Acute Disease; Alprostadil; Animals; Antioxidants; Aryldialkylphosphatase; Biomarkers; Disease Models, Animal; Double-Blind Method; Free Radical Scavengers; Homocysteine; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Oxidative Stress; Oxytetracycline; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Treatment Outcome | 2003 |
The effects of melatonin and prostaglandin E1 analogue on experimental hepatic ischaemia reperfusion damage.
Topics: Alanine Transaminase; Alprostadil; Animals; Antioxidants; Aspartate Aminotransferases; Erythrocytes; Female; Ischemia; Liver; Malondialdehyde; Melatonin; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase | 2003 |
Treatment approaches to irritable bowel syndrome.
Topics: Alprostadil; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Child, Preschool; Clinical Trials as Topic; Cognitive Behavioral Therapy; Dietary Fiber; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Melatonin; Parasympatholytics; Pediatrics; Physician's Role; Primary Health Care; Probiotics; Treatment Outcome | 2009 |
Evaluation of melatonin and prostaglandin E1 combination on necrotizing enterocolitis model in neonatal rats.
Topics: Alprostadil; Animals; Animals, Newborn; Drug Therapy, Combination; Enterocolitis, Necrotizing; Female; Melatonin; Pregnancy; Rats; Rats, Sprague-Dawley | 2013 |